Contributing to Türkiye’s accomplishments in the healthcare sector, Dem İlaç is gaining recognition via a distinctive investment in Yalova. Founded in 2016 and commenced in 2022, Dem İlaç’s Production Facility.
Dem Pharmaceutical Production Facility stands out as a facility equipped with modern architecture and state-of-the-art equipment. Dem İlaç, which adopts high quality standards and has international certifications, produces effective and safe medicines by using the most up-to-date techniques in the production process.
Dem İlaç, which made the investment, has given a significant impetus to the economic development of the region by establishing a production center in Yalova. The local workforce employed at the facility contributes to the local economy by increasing the employment rate in the region.
The opening of the Dem Pharmaceutical Production Facility increases Turkey’s power and competitiveness in the pharmaceutical industry. The production of high-quality and effective medicines plays an important role in meeting the health needs of patients. Dem İlaç aims to have a leading position in the healthcare industry with its innovative approach and research and development studies in its production facility.
Dem Pharmaceutical Production Facility opened in Yalova makes significant contributions to both the economic development of the region and the growth of the pharmaceutical industry throughout the country. This successful investment is just one of the important steps taken to increase Turkey’s potential and global competitiveness in the healthcare sector.
